Ciruelos, E. http://orcid.org/0000-0002-2796-1042
Jerusalem, G.
Martin, M.
Tjan-Heijnen, V. C. G.
Neven, P.
Gavila, J.
Montemurro, F.
Generali, D.
Lang, I.
Martínez-Serrano, M. J.
Perelló, M. F.
Conte, P.
Article History
Received: 12 November 2019
Accepted: 19 February 2020
First Online: 13 March 2020
Compliance with ethical standards
:
: E. Ciruelos declare her participation in advisory boards of Roche, Lilly, Pfizer and Novartis and received speakers’ honoraria from Roche, Lilly, Pfizer and Novartis as well as non-financial support from Roche. G. Jerusalem declare research grants from Novartis, Roche and Pfizer, personal fees from Novartis, Roche, Pfizer, Lilly, Celgene, Amgen, BMS and AstraZeneca, and non-financial support from Novartis, Roche, Lilly, Pfizer, Amgen, BMS and AstraZeneca. M. Martin declare research grants from Roche and Novartis, speaker’s honoraria from Roche, AstraZeneca, GSK, Pfizer and Lilly and participated in advisory boards of Roche, AstraZeneca, GSK, Lilly, Pfizer Taiho and Pharmamar. V. C. G. Tjan-Heijnen declare research grants and non-financial support from Novartis, Pfizer, Roche, Lilly and AstraZeneca. J. Gavila declare speakers’ honoraria and participation in advisory boards from Pfizer, Roche and Novartis. F. Montemurro declare speakers’ honoraria from Novartis, Lilly and Pfizer and participated in advisory boards of Roche. D. Generali declare speakers’ honoraria from Novartis, Lilly and Pfizer. M. J. Martínez-Serrano and M. F. Perelló are Novartis’ employees. P. Neven and I. Lang and P. Conte declare that they have no conflict of interest.
: This study has been performed in accordance with the ethical standards of the Declaration of Helsinki and its later amendments and comply with the current laws of the countries in which they were performed.
: Informed consent was obtained from all individual participants of this study.